Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Biomedicines
2022 Jan 08;101:. doi: 10.3390/biomedicines10010134.
Show Gene links
Show Anatomy links
Chlorin Endogenous to the North Pacific Brittle Star Ophiura sarsii for Photodynamic Therapy Applications in Breast Cancer and Glioblastoma Models.
Klimenko A
,
Rodina EE
,
Silachev D
,
Begun M
,
Babenko VA
,
Benditkis AS
,
Kozlov AS
,
Krasnovsky AA
,
Khotimchenko YS
,
Katanaev VL
.
Abstract
Photodynamic therapy (PDT) represents a powerful avenue for anticancer treatment. PDT relies on the use of photosensitizers-compounds accumulating in the tumor and converted from benign to cytotoxic upon targeted photoactivation. We here describe (3S,4S)-14-Ethyl-9-(hydroxymethyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoic acid (ETPA) as a major metabolite of the North Pacific brittle stars Ophiura sarsii. As a chlorin, ETPA efficiently produces singlet oxygen upon red-light photoactivation and exerts powerful sub-micromolar phototoxicity against a panel of cancer cell lines in vitro. In a mouse model of glioblastoma, intravenous ETPA injection combined with targeted red laser irradiation induced strong necrotic ablation of the brain tumor. Along with the straightforward ETPA purification protocol and abundance of O. sarsii, these studies pave the way for the development of ETPA as a novel natural product-based photodynamic therapeutic.
Figure 1. Analytical (A) and semi-preparative (B) chromatography of the butanol fraction of the EtOH extract of O. sarsii, absorption intensity at the wavelength of 366 nm (A) and 210 nm/366 nm (B). The major peak at the retention time of 52 min (A) and 35 min (B) corresponds to ETPA (chlorin) from our previous study [10]. Chromatograms from non-fasted ophiuras are shown in both panels; samples from the fasted ophiuras show identical chromatograms.
Figure 2. (A) Absorbance spectra of the chlorin compound isolated from the butanol fraction of the EtOH extract from control (red) and fasted (black) O. sarsii reveal absorbance peaks typical for chlorins, identical between the two preparations; (B) cell survival (MTT test) to evaluate the strong phototoxicity of ETPA after red-light irradiation. Data are given as mean ± SEM, n = 8 (3 for HEK-293 cells); (C) ETPA phototoxicity IC50 and the phototoxicity index (PI, calculated as IC50 in the dark/IC50 in the light [17]). Cell survival data in the dark are taken from [10] (breast cancer cell lines) or measured separately (C6 and HEK-293 cells, see Supplementary Figure S4).
Figure 3. ETPA efficiently generates singlet oxygen: (A) changes in the absorption spectrum of DPIBF (curves 1–4) in the mixture of DPIBF with ETPA in acetone during irradiation by monochromatic red light (660 nm) absorbed by ETPA. Here, “2” corresponds to 2 min, “3” refers to 5 min, and “4” to 15 min irradiation. Power of exciting light was 83 μW. Inset shows the time course of 414 nm absorption fall of DPIBF. ETPA bleaching was not observed; (B) the relative quantum yields of DPIBF oxidation (Vr/n) upon irradiation of TPP and ETPA. The rate of spontaneous DPIBF bleaching in the dark without sensitizer and irradiation is defined as “Control”. For TPP, irradiation time was 10 min, excitation wavelength was 512 nm, irradiation power was 105 μW, and absorbance of TPP at 512 nm was 0.024. For ETPA, irradiation time was 2 min, excitation wavelength was 660 nm, excitation power was 83 μW, and absorbance at 660 nm was 0.095; (C) kinetic trace of photosensitized phosphorescence of singlet oxygen upon excitation of ETPA by 5 μs pulses of violet LED (399 nm) in cartesian (1) and semilogarithmic (2) coordinates. Pulse repetition rate was 5 kHz, average LED power was 30 mW, and irradiation (averaging) time was 10 min. The PMT signal was accumulated using a time-resolved computer photon counting. The duration of one channel was 640 ns, and the number of channels was 256. Absorbance of the solution at 396 nm was 0.246 in a 1 cm quartz cell. Here, “3” indicates phosphorescence emission spectrum estimated using three interchangeable interference filters. I corresponds to the phosphorescence intensity just after the end (5 μs) of the LED pulse. The decay time (τΔ) of the phosphorescence exactly coincided with the known value of singlet oxygen lifetime in acetone; (D) calculation of the quantum yield of singlet oxygen by ETPA in comparison with phenalenone.
Figure 4. PDT using ETPA in a mouse model of glioblastoma: (A) scheme of the experiment; (B,C) representative T2-weighted MR images from coronal brain sections (0.5 mm thick) obtained 5 days after PDT. The area outlined with a red line refers to hyperintensities regions (edema, B). The area outlined with a blue line refers to PDT-induced glioma necrosis (C); (D) a representative histological section, stained with eosin–hematoxylin, demonstrates the tumor boundaries (outlined in black) and the presence of necrotic loci in the area of laser illumination (outlined in yellow); (E) enlarged area showing the boundaries of necrotic and intact tumor tissues. Images shown are representative of 3 animals.
Akimoto,
Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas.
2012, Pubmed
Akimoto,
Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas.
2012,
Pubmed
Auer,
A simple and reproducible experimental in vivo glioma model.
1981,
Pubmed
Aziz,
Photodynamic therapy adjuvant to surgery in metastatic carcinoma in brain.
2009,
Pubmed
Baskaran,
Clinical development of photodynamic agents and therapeutic applications.
2018,
Pubmed
Blagodatski,
High-throughput targeted screening in triple-negative breast cancer cells identifies Wnt-inhibiting activities in Pacific brittle stars.
2017,
Pubmed
,
Echinobase
Calestani,
These Colors Don't Run: Regulation of Pigment-Biosynthesis in Echinoderms.
2018,
Pubmed
,
Echinobase
Cameron,
SpBase: the sea urchin genome database and web site.
2009,
Pubmed
,
Echinobase
Cho,
Remodeling of Neuronal Circuits After Reach Training in Chronic Capsular Stroke.
2016,
Pubmed
Dougherty,
Introduction.
2010,
Pubmed
Fan,
Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma.
2021,
Pubmed
Grobben,
Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion.
2002,
Pubmed
Hill,
Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer.
1995,
Pubmed
Hill,
Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma.
1992,
Pubmed
Irtenkauf,
Optimization of Glioblastoma Mouse Orthotopic Xenograft Models for Translational Research.
2017,
Pubmed
Katanaev,
Mining Natural Compounds to Target WNT Signaling: Land and Sea Tales.
2021,
Pubmed
Katanaev,
The Anticancer Drug Discovery Potential of Marine Invertebrates from Russian Pacific.
2019,
Pubmed
Kaye,
Photoradiation therapy causing selective tumor kill in a rat glioma model.
1987,
Pubmed
Kennedy,
Porphyrins in invertebrates.
1975,
Pubmed
Klimenko,
A Cytotoxic Porphyrin from North Pacific Brittle Star Ophiura sarsii.
2020,
Pubmed
,
Echinobase
Krasnovsky,
Photochemical investigation of the IR absorption bands of molecular oxygen in organic and aqueous environment.
2012,
Pubmed
Krasnovsky,
Kinetic Measurements of Singlet Oxygen Phosphorescence in Hydrogen-Free Solvents by Time-Resolved Photon Counting.
2019,
Pubmed
Li,
Clinical development and potential of photothermal and photodynamic therapies for cancer.
2020,
Pubmed
Mao,
Genome-wide identification, characterisation and expression analysis of the ALAS gene in the Yesso scallop (Patinopecten yessoensis) with different shell colours.
2020,
Pubmed
Nair,
A simple practice guide for dose conversion between animals and human.
2016,
Pubmed
Olzowy,
Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid.
2002,
Pubmed
Padrutt,
Highly Phototoxic Transplatin-Modified Distyryl-BODIPY Photosensitizers for Photodynamic Therapy.
2021,
Pubmed
Pandey,
Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy.
2006,
Pubmed
Quirk,
Photodynamic therapy (PDT) for malignant brain tumors--where do we stand?
2015,
Pubmed
Romanova,
Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex.
2006,
Pubmed
Tan,
Management of glioblastoma: State of the art and future directions.
2020,
Pubmed
Tzerkovsky,
Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models.
2014,
Pubmed
Zhang,
Combination of surgical resection and photodynamic therapy of 9L gliosarcoma in the nude rat.
2006,
Pubmed